CEO of Globus Medical Inc (GMED, Financial) David M Demski sold 149,109 shares of GMED on 04/19/2018 at an average price of $51 a share. The total sale was $7.6 million.
Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment. Globus Medical Inc has a market cap of $5.03 billion; its shares were traded at around $52.09 with a P/E ratio of 47.33 and P/S ratio of 7.98. Globus Medical Inc had annual average EBITDA growth of 10.40% over the past five years.
CEO Recent Trades:
- CEO David M Demski sold 149,109 shares of GMED stock on 04/19/2018 at the average price of $51. The price of the stock has increased by 2.14% since.
- CEO David M Demski sold 50,891 shares of GMED stock on 04/13/2018 at the average price of $51. The price of the stock has increased by 2.14% since.
CFO Recent Trades:
- Senior VP and CFO Daniel T Scavilla sold 100,000 shares of GMED stock on 04/10/2018 at the average price of $50. The price of the stock has increased by 4.18% since.
Directors and Officers Recent Trades:
- Senior VP and General Counsel Eric Schwartz sold 24,000 shares of GMED stock on 03/28/2018 at the average price of $50. The price of the stock has increased by 4.18% since.
For the complete insider trading history of GMED, click here
.
